Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Similar documents
Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Asymptomatic Valvular Disease:

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Chronic Primary Mitral Regurgitation

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

What is the Role of Surgical Repair in 2012

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Organic mitral regurgitation

What echo measurements are key prior to MitraClip?

How to assess ischaemic MR?

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Primary Mitral Regurgitation

Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative?

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

The difficult patient with mitral regurgitation

Emergency Intraoperative Echocardiography

MitraClip in the ICCU: Which Patient will Benefit?

Repair or Replacement

8/31/2016. Mitraclip in Matthew Johnson, MD

Guidelines in perspective?

(Ann Thorac Surg 2008;85:845 53)

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

Posterior leaflet prolapse is the most common lesion seen

Aortic stenosis with concomitant mitral regurgitation

When Does 3D Echo Make A Difference?

Atrioventricular valve repair: The limits of operability

Mitral Valve Disease, When to Intervene

Tricuspid and Pulmonary Valve Disease

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD

Echocardiographic Evaluation of Primary Mitral Regurgitation

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Disclosures Rebecca T. Hahn, MD, FASE

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

Mitral Regurgitation

Quality Outcomes Mitral Valve Repair

The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Index. B B-type natriuretic peptide (BNP), 76

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Μαρία Δρακοπούλου, Σοφία Βαïνά

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

Basic principles of Rheumatic mitral valve Repair

Prognostic Impact of FMR

Cases of mitral valve causing mitral regurgitation: the MV prolapse spectrum CASE

Use of MitraClip Beyond Everest Criteria

Improving Quality of Care for Patients with Heart Valve Disease

I have financial relationships to disclose Honoraria from: Edwards

Surgery For Ebstein Anomaly

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management

Mitral Regurgitation:

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F.

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

CARDIOLOGY GRAND ROUNDS

Treatment options in ischaemic mitral regurgitation: surgery, clips, devices?

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Echo in Asymptomatic Mitral and Aortic Regurgitation

Management of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

Steven F Bolling Professor of Cardiac Surgery University of Michigan

Tricuspid and Pulmonary Valve Disease

Ischemic Mitral Regurgitation

Prosthetic valve dysfunction: stenosis or regurgitation

Clinical Value of 3D Echo: Volumes and Valves

What is the Definition of Small Systemic Ventricle. Hong Ryang Kil, MD Department of Pediatrics, College of Medicine, Chungnam National University

Imaging to select patients for Transcatheter TV

Concomitant Tricuspid Valve Repair :

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Ischaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Understanding the guidelines for Interventions in MR. Ali AlMasood

Management of TR in Patients Undergoing Mitral Interventions

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Basic Principles of Degenerative Mitral Valve Repair Technical Aspects and Results. Manuel Antunes Coimbra-Portugal

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Next Generation Therapies: Aortic, Mitral and Beyond

Conflict of Interests

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Transcription:

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

MV anatomy Otto C. NEJM 2001

Leaflets anatomy

2% of population Etiology

Terminology Lancellotti P. Eur J Echocardiogr 2010

Spectrum of degenerative mitral disease

Spectrum of degenerative mitral disease Barlow s disease Fibroelastic deficiency

3D imaging Barlow s disease Fibroelastic deficiency

Valve dysfunction

Valve dysfunction

Carpentier s pathophysiologic triad Disease that causes MR Resulting lesions Resulting valvular dysfunction

Role of echo Preop or prepump - Severity of regurgitation - Precise anatomy and dysfunction of valve - LV and RV size and function - Other valve problems (esp TV) Postpump -?Residual regurgitation + mechanism - MV SAM LVOT obstruction - LV and RV size and function - Iatrogenic complications

Severity of MR Lancellotti P. Eur J Echocardiogr 2010

Calculation of ERO with PISA

Significance of MR quantification n = 456 pts with asymptomatic organic MR 63 ± 14 y Enriquez-Sarano M et al. NEJM 2005 EF = 70 ±8 (excluded EF < 50%) ESD = 34 ± 6 MV surgery (91% MV repair) reduced risk of death

Limitations of intraoperative TOE Optimal loading conditions (reduction of afterload or intravascular volume) May underestimate severity esp in ischaemic MR Increase intravascular volume - use iv phenylephrine Nyquist limit = 50 60 cm/s

Precise anatomy and mechanism of MR Why is it so important? Omran AS et al. JASE 2002 Adams DH et al. Cur Opin Cardiol 2008

n = 394 pts with flail MV and MR (64% NYHA I-II) 102 pts NYHA I and EF > 60% 64 ± 11 y EF = 67 ±10 ESD = 35 ± 7 MV surgery in 80% - MV repair (80%) better than MV replacement MV repair better than MV replacement Grigioni F et al. JACC Card Imag 2008

Systematic 2D TOE examination 60 90 60 90 0-20 135 0-20 135

3D TOE

3D TOE

3D vs 2D TOE Salcedo E et al. JASE 2009

Flail P1

Flail PM commissure

3D reconstruction

LV dysfunction EF < 60% n = 409 pts operated for severe organic MR 64 ± 13 y EF = 62 ± 11 ESD = 38 ± 9 Enriquez-Sarano M et al. Circulation 1994

LV dysfunction Florescu M et al. Echocardiography 2011

LV size ESD > 40 mm n = 739 pts with flail MV and MR (69% NYHA I-II) 65 ± 12 y EF = 65 ±10 ESD = 35 ± 7 Tribouilloy C et al. JACC 2009

Don t forget the tricuspid valve

TV annulus diameter 3.5 cm 4.7 cm

Guidelines ESC AHA/ACC

TV repair Interact CardioVasc Thorac Surg 2009

Valve repair procedures Carpentier s method Respect rather than resect - neochordae

Postpump?Residual regurgitation + mechanism MV SAM LVOT obstruction LV and RV size and function Iatrogenic complications

?Mitral regurgitation Leaflet coaptation line = 5 8 mm Assess after LV function and loading conditions are relatively normal (off pump) If more than mild assess mechanism 4 11% second pump run

SAM 2 9 % of patients in older series Usually occurs in patients with large mitral leaflets and a small hyperdynamic ventricle Initial management: stop inotropes and increase intracardiac volume If problem persist second pump run

Echo predictors of SAM Maslow AD et al. JACC 1999

SAM

LV dysfunction Early dysfunction cardioplegia and/or umasking due to reduced preload after correction of MR (global) If regional suspect air emboli (usually RCA)

Mitral stenosis Very unusual in degenerative MR Mean G > 5 mmhg PHT not reliable

Dehisced annuloplasty ring

Mitral clip

Mitral clip

EVEREST II 74% degenerative MR Feldman T et al. NEJM 2011

EVEREST II editorial

Summary Echo provides invaluable information in patients with degenerative MR Preop 3D echo = surgeon s eye view better planning of the operation Post op assessment of residual MR and potentially lethal complications if unrecognized

Back up slides Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Systematic 2D TOE examination LAX LAX Bicom Bicom Lambert AS et al. Anesth Analg 1999

Systematic 2D TOE examination 0 20

60 Systematic 2D TOE examination

90 Systematic 2D TOE examination

Systematic 2D TOE examination 90

120 Systematic 2D TOE examination

Systematic 2D TOE examination

0-20 Case A2 P2

60 Case P3 A2 P1

Case 90 135 P3 A3-A2-A1 P2 A2

Case P2 A2